Methuselah Health UK Limited is a drug discovery company founded in 2015 by Index Ventures to study the role of proteome instability in a number of human diseases linked to ageing.

The ageing process underlies development of many major diseases of middle and old age – diseases that are poorly treated by existing drugs. These diseases represent the biggest unmet medical need in the developed world, a situation unlikely to change for several decades.

We will develop analytical platforms for the detection of post translational modifications across many different proteins. Following validation of the platforms we will use the methods developed to identify novel candidate targets in the pathogenesis of ageing-related diseases.

In the future we hope to take these new leads and both increase understanding of these complex human diseases and develop drugs to treat them.